Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -5.73%.
RETURN ON ASSETS (ROA)
N/A
RETURN ON ASSETS (ROA) AVG TTM
-21.71%
RETURN ON ASSETS (ROA) AVG 3Y
-73.35%
RETURN ON ASSETS (ROA) AVG 5Y
-116.85%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Polyrizon Ltd.
Market Cap
$10.83M
Return on Assets (ROA)
N/A
TTM Avg
-21.71%
3Y Avg
-73.35%
5Y Avg
-116.85%
Market Cap
$10.84M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$10.91M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$11.04M
Return on Assets (ROA)
-154.89%
TTM Avg
-40.68%
3Y Avg
-87.98%
5Y Avg
-439.28%
Market Cap
$10.59M
Return on Assets (ROA)
-148.79%
TTM Avg
-109.24%
3Y Avg
-211.74%
5Y Avg
-146.61%
Market Cap
$10.59M
Return on Assets (ROA)
-98.26%
TTM Avg
-77.06%
3Y Avg
-65.68%
5Y Avg
-62.77%
Market Cap
$10.56M
Return on Assets (ROA)
-132.59%
TTM Avg
-75.28%
3Y Avg
-65.73%
5Y Avg
-52.31%
Market Cap
$11.12M
Return on Assets (ROA)
-46.21%
TTM Avg
-17.41%
3Y Avg
-49.70%
5Y Avg
-52.01%
Market Cap
$10.52M
Return on Assets (ROA)
-88.09%
TTM Avg
-90.94%
3Y Avg
-60.82%
5Y Avg
-50.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.83M | N/A | -21.71% | -73.35% | -116.85% |
| Cerenome, Inc. (CNSY)vs › | $10.84M | -185.94% | -166.39% | -133.67% | -110.62% |
| Caring Brands, Inc. (CABR)vs › | $10.91M | -404.58% | -269.82% | -269.82% | -269.82% |
| BioVie Inc. (BIVI)vs › | $11.04M | -154.89% | -40.68% | -87.98% | -439.28% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.59M | -148.79% | -109.24% | -211.74% | -146.61% |
| Pluri Inc. (PLUR)vs › | $10.59M | -98.26% | -77.06% | -65.68% | -62.77% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -132.59% | -75.28% | -65.73% | -52.31% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | -46.21% | -17.41% | -49.70% | -52.01% |
| Lifeward Ltd. (LFWD)vs › | $10.52M | -88.09% | -90.94% | -60.82% | -50.49% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -37.02% | -41.41% | -41.74% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -15.56% |
| 2024-12-31 | -27.85% |
| 2023-12-31 | -107.33% |
| 2022-12-31 | -142.67% |
| 2021-12-31 | -103.49% |
| 2020-12-31 | -304.17% |
